252 related articles for article (PubMed ID: 16141367)
1. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).
Bourdet DL; Pritchard JB; Thakker DR
J Pharmacol Exp Ther; 2005 Dec; 315(3):1288-97. PubMed ID: 16141367
[TBL] [Abstract][Full Text] [Related]
2. Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters.
Ming X; Ju W; Wu H; Tidwell RR; Hall JE; Thakker DR
Drug Metab Dispos; 2009 Feb; 37(2):424-30. PubMed ID: 18971316
[TBL] [Abstract][Full Text] [Related]
3. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.
Hayer-Zillgen M; Brüss M; Bönisch H
Br J Pharmacol; 2002 Jul; 136(6):829-36. PubMed ID: 12110607
[TBL] [Abstract][Full Text] [Related]
4. Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters.
Kang HJ; Lee SS; Lee CH; Shim JC; Shin HJ; Liu KH; Yoo MA; Shin JG
Drug Metab Dispos; 2006 Jul; 34(7):1145-51. PubMed ID: 16624869
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates.
Umehara KI; Iwatsubo T; Noguchi K; Kamimura H
Xenobiotica; 2007 Jun; 37(6):618-34. PubMed ID: 17614008
[TBL] [Abstract][Full Text] [Related]
6. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT).
Müller J; Lips KS; Metzner L; Neubert RH; Koepsell H; Brandsch M
Biochem Pharmacol; 2005 Dec; 70(12):1851-60. PubMed ID: 16263091
[TBL] [Abstract][Full Text] [Related]
7. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2.
Kimura N; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Apr; 77(8):1429-36. PubMed ID: 19426682
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).
Yonezawa A; Masuda S; Yokoo S; Katsura T; Inui K
J Pharmacol Exp Ther; 2006 Nov; 319(2):879-86. PubMed ID: 16914559
[TBL] [Abstract][Full Text] [Related]
9. A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters.
Tahara H; Kusuhara H; Endou H; Koepsell H; Imaoka T; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2005 Oct; 315(1):337-45. PubMed ID: 16006492
[TBL] [Abstract][Full Text] [Related]
10. Carrier-mediated uptake of H2-receptor antagonists by the rat choroid plexus: involvement of rat organic anion transporter 3.
Nagata Y; Kusuhara H; Hirono S; Endou H; Sugiyama Y
Drug Metab Dispos; 2004 Sep; 32(9):1040-7. PubMed ID: 15319347
[TBL] [Abstract][Full Text] [Related]
11. The organic cation transporters rOCT1 and hOCT2 are inhibited by cGMP.
Schlatter E; Mönnich V; Cetinkaya I; Mehrens T; Ciarimboli G; Hirsch JR; Popp C; Koepsell H
J Membr Biol; 2002 Oct; 189(3):237-44. PubMed ID: 12395288
[TBL] [Abstract][Full Text] [Related]
12. Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3.
Haenisch B; Drescher E; Thiemer L; Xin H; Giros B; Gautron S; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):1017-23. PubMed ID: 22806583
[TBL] [Abstract][Full Text] [Related]
13. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
[TBL] [Abstract][Full Text] [Related]
14. Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A).
Motohashi H; Uwai Y; Hiramoto K; Okuda M; Inui K
Eur J Pharmacol; 2004 Oct; 503(1-3):25-30. PubMed ID: 15496291
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human organic cation transporters by the alkaloids matrine and oxymatrine.
Pan X; Wang L; Gründemann D; Sweet DH
Fitoterapia; 2014 Jan; 92():206-10. PubMed ID: 24291757
[TBL] [Abstract][Full Text] [Related]
16. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
Zhang L; Schaner ME; Giacomini KM
J Pharmacol Exp Ther; 1998 Jul; 286(1):354-61. PubMed ID: 9655880
[TBL] [Abstract][Full Text] [Related]
18. Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1).
Dresser MJ; Gray AT; Giacomini KM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1146-52. PubMed ID: 10688634
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the human organic cation transporter hOCT1.
Ciarimboli G; Struwe K; Arndt P; Gorboulev V; Koepsell H; Schlatter E; Hirsch JR
J Cell Physiol; 2004 Dec; 201(3):420-8. PubMed ID: 15389554
[TBL] [Abstract][Full Text] [Related]
20. Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.
Wagner DJ; Duan H; Chapron A; Lee RW; Wang J
Xenobiotica; 2017 Dec; 47(12):1112-1120. PubMed ID: 27977936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
